Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. - Fichtner-Feigl,S.; Fuss,I.J.; Preiss,J.C.; Strober,W.; Kitani,A. (The Journal of Clinical Investigation, 2005)